Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesLaparoscopic Radical Nephrectomy for Patients with T2 and T3 Renal-Cell Carcinoma: Evaluation of Perioperative Outcomes
Journal of Endourology, 08/28/09
Bird VG et al. – LRN for the treatment of clinical stage T2 and T3 disease should be considered. LRN can be safely performed with good perioperative outcome. Blood transfusion and complication rates are higher for LRN in pT2/T3 patients. However, the decision to modify surgical technique should be considered when either oncologic efficacy or patient safety is a concern.
Related Articles
Clinical Characteristics of Renal Cell Carcinoma in Korean Patients with von Hippel-Lindau Disease Compared to Sporadic Bilateral or Multifocal Renal Cell Carcinoma
Journal of Korean Medical Science, 11/16/09
Relevance Score: 84%
Metastatic Renal Cell Carcinoma: Recent Advances in the Targeted Therapy Era
European Urology, 11/03/09
Relevance Score: 84%
Population-based survey of cancer risks in chromosome 3 translocation carriers
Genes, Chromosomes and Cancer, 10/28/09
Relevance Score: 84%
Apolipoprotein E/C1 Locus Variants Modify Renal Cell Carcinoma Risk
Cancer Research, 10/20/09
Relevance Score: 84%
Surgical Treatment of Renal Cell Carcinoma in the Immunocompromised Transplant Patient
Urology, 10/12/09
Relevance Score: 84%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma
Journal of Clinical Oncology, 12/18/09
Renal cell carcinoma with caval involvement: Contemporary strategies of surgical treatment
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Antiproliferative and apoptosis inducing effects of indirubin-3'-monoxime in renal cell cancer cells
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Article Search
Sponsor